描述 |
Natamycin (pimaricin)是抗真菌化合物。 |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
相关类别 |
|
||||||||||||
溶解度 |
体外:
DMSO:10.75 mg / mL(16.15 mM;需要加温)
|
||||||||||||
储备液 |
|
||||||||||||
存储 |
|
||||||||||||
运输 |
室温;可能会有所不同 |
||||||||||||
SMILES |
OC([C@H]1[C@@](C[C@H](/C=C/C=C/C=C/C=C/C[C@@H](C)OC2=O)O[C@@](O[C@H](C)[C@@H](O)[C@@H]3N)([H])[C@H]3O)([H])O[C@](O)(C[C@H](C[C@]4([H])[C@@H](/C=C/2)O4)O)C[C@@H]1O)=O |
||||||||||||
参考文献 |
|
||||||||||||
相关活性 小分子 |
放线菌酮 | 潮霉素B | 醋酸卡泊芬净 | 5-氟胞嘧啶 | 泊沙康唑 | 特比萘芬 | 环吡酮胺 | 艾沙康唑 | 阿尼芬净 | 克霉唑 | 氯碘羟喹 | 硝酸咪康唑 | 长川霉素 | 硝酸益康唑 | 三氯生 |
密度 | 1.4±0.1 g/cm3 |
---|---|
沸点 | 952.2±65.0 °C at 760 mmHg |
熔点 | 2000?C |
分子式 | C33H47NO13 |
分子量 | 665.725 |
闪点 | 529.7±34.3 °C |
精确质量 | 665.304749 |
PSA | 230.99000 |
LogP | 0.74 |
外观性状 | 白色至灰白色固体 |
蒸汽压 | 0.0±0.6 mmHg at 25°C |
折射率 | 1.620 |
储存条件 |
2-8℃ |
分子结构 |
1、 摩尔折射率:167.73 2、 摩尔体积(m3/mol):477.4 3、 等张比容(90.2K):1385.8 4、 表面张力(dyne/cm):71.0 5、 极化率(10-24cm3):66.49 |
更多 |
1. 性状:近白色到奶油黄色粉末,几乎无臭无味 2. 密度(g/mL 25?C):1 3. 相对蒸汽密度(g/mL,空气=1):未确定 4. 熔点(?C):2000 5. 沸点(?C,常压):未确定 6. 沸点(?C,5.2kPa):未确定 7. 折射率(n20/D):未确定 8. 闪点(?C,):未确定 9. 比旋光度(?):-未确定 10. 自燃点或引燃温度(?C):未确定 11. 蒸气压(kPa,25?C):未确定 12. 饱和蒸气压(kPa,60?C):未确定 13. 燃烧热(KJ/mol):未确定 14. 临界温度(?C):未确定 15. 临界压力(KPa):未确定 16. 油水(辛醇/水)分配系数的对数值(25℃):未确定 17. 爆炸上限(%,V/V):未确定 18. 爆炸下限(%,V/V):未确定 19. 溶解性(mg/mL):几不溶于水,微溶于甲醇,溶于冰醋酸和二甲基亚砜 |
|
纳他霉素毒性英文版
|
个人防护装备 |
Eyeshields;Gloves |
---|---|
危害码 (欧洲) |
Xn: Harmful; |
风险声明 (欧洲) |
R22 |
安全声明 (欧洲) |
S24/25 |
危险品运输编码 | NONH for all modes of transport |
WGK德国 | 2 |
RTECS号 | TK3325000 |
~%
纳他霉素
7681-93-8
|
文献:EP1862467 A2, ; Page/Page column 5; 24; 29 ; |
~%
纳他霉素
7681-93-8
|
文献:EP1862467 A2, ; Page/Page column 5; 24; 29 ; |
由游链霉菌(Streptomyces natalensis)受控发酵制得
Phytochemicals preservation in strawberry as affected by pH modulation. Food Chem. 170 , 74-83, (2014)
Strawberries purées are incorporated in foods and subjected to pH modulation according to the expected final food matrix. The effect of pH on strawberry polyphenols stored at 4 and 23 °C for 90 days w…
|
|
Amphotericin-B entrapped lecithin/chitosan nanoparticles for prolonged ocular application. Int. J. Biol. Macromol. 72 , 1451-8, (2014)
Fungal keratitis is the major cause of vision loss worldwide. Amphotericin-B is considered as the drug of choice for fungal infections. However, its use in ophthalmic drug delivery is limited by the l…
|
|
Corneal targeted nanoparticles for sustained natamycin delivery and their PK/PD indices: an approach to reduce dose and dosing frequency. Int. J. Pharm. 477(1-2) , 317-25, (2014)
Natamycin is the only approved medication for the treatment of mycotic keratitis. Current dosage regimen include one drop of natamycin suspension (5% w/v) instilled in the conjunctival sac at hourly o…
|
|
Natamycin |
Synogil |
Pimaricin |
EINECS 231-683-5 |
PIMAFUCIN |
myprozine |
MFCD00135085 |
delvocid |
antibiotic A 5283 |
mycophyt |
delvopos |
(8E,14E,16E,18E,20E)-(1R,3S,5R,7R,12R,22R,24S,25R,26S)-22-(3-amino-3,6-dideoxy-β-D-mannopyranosyloxy)-1,3,26-trihydroxy-12-methyl-10-oxo-6,11,28-trioxatricyclo[22.3.1.05,7]octacosa-8,14,16,18,20-pentaene-25-carboxylic acid |
natacyn |
delvolan |
cl12,625 |
(1R,3S,5R,7R,8E,12R,14E,16E,18E,20E,22R,24S,25R,26S)-22-[(3-amino-3,6-dideoxy-β-D-mannopyranosyl)oxy]-1,3,26-trihydroxy-12-methyl-10-oxo-6,11,28-trioxatricyclo[22.3.1.05,7]octacosa-8,14,16,18,20-pentaene-25-carboxylic acid |